Hepatopatía crónica

Evaluación de sobrevida en pacientes cirróticos por virus C mediante la escala de Child-Pugh e índice Meld

Los factores que influyen en la sobrevida del paciente con cirrosis son la etiología, edad, clase funcional y presencia de complicaciones.

Autor/a: Juan Buelna, Mauricio Cruz, Gloria Patiño, Ana Laura Muñoz; Hospital General IMSS, Celaya, Guanajuato

Fuente: Revista Dolor Año 7/ Vol. III/ 2010

Indice
1. Bibliografía
2. Desarrollo

1. Gayton A, Holl J. Tratado de Fisiología Médica. 9a Ed. MG.

2. Joel J, Heidelbough, Bruderly M. Cirrhosis and chronic liver failure Part I. Diagnosis and evaluation. Am Fam Physician 2006; 74:756-762, 781.

3. Consenso Mexicano sobre el Diagnóstico y Tratamiento de la Cirrosis Hepática, Asociación Mexicana de Hepatología, Informe preliminar 10 de junio 2007.

4. Sherlock S. European livers. Lancet.

5. Aspectos relevantes sobre la estadística de egresos hospitalarios del Sistema Nacional de Salud.

6. Nahum Méndez- Sánchez Juan R. Aguilar-Ramírez, et al. Etiology of liver Cirrhosis in Mexico. Annals of Hepatology 2004; 3(1): 30-33.

7. Broundwold E. Houser S, Fauci A. Cirrosis y sus complicaciones. Ed. Al Harrison.

8. Gennaro D Amico, Guadalupe Garcia-Tsao, Luigi Pagliaro. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. Journal of Hepatology 2006; 44: 217-231.

9. Child, CG, Turcotte, SG. Surgery and portal hypertension. En: The Liver and Portal Hypertension, Child. CG Ed, Sounders, Philadelphia 1964; p. 50.

10. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transaction of the esophagus for bleeding vesophogeal varices. BR J Surg 1973; 60:646.

11. Lucey MR, Brown KA, Everson GT, Fung JJ, Gish R, Keeffe EB, Kneteman NM, Lake JR, Martin P, McDiarmid SV, Rakela J, Shiffman ML, So SK, Wiesner RH. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg 1997; 3(6): 628-637.

12. Christensen E, Schlichting P, Fauerholdt L, et al. Prognostic value of Child- Turcotte criteria in medically treated cirrhosis. Hepatology 1984; 4:430.

13. Ziser A, Plevak DJ, Wiesner RH, et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology. 1999; 90: 42-53.

14. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464.

15. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:464.

16. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease and allocation of donor livers. Gastroenterology 2003; 124: 91.

17. Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8:851.

18. Heunan DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. J Hepatology 2004; 40:802.

19. Institute of Medicine. Analysis of waiting times. In Comite on Organ Transplantation. Assesing current policies and the potential impact of the DHHS final rule. Washington DC. National Academy Press. 1999.

20. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatology 2004; 40:897.

21. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. J Hepatology 2005; 41: 1282.

22. Terra C, Guevara M, Torre A, Gilbert R. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: Value of MELD score. Gastroenterology 2005; 129:1944.

23. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 2005; 41: 1122.

24. Kiran Bamba, Patrick S Kamath. Model for End-stage Liver Disease. Update 2006.

25. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease in the setting of liver transplantation. Liver Tanspl 2006; 12: 1049.

26. Freeman RB, Wiesner RH, Edwards E, et al. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10:4.

27. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464.